The immunological synapse is a specialized intercellular junction between a T cell and a target cell that orchestrates the engagement of receptors and ligands in space and time as a means of regulating function. Here we introduce a reagent for controlling the spatial and temporal presentation of natural antigen to T cells. Moth cytochrome c (88-103) peptide (MCC), an agonist to the murine T cell receptor AND when presented in the context of H2 IEk major histocompatibility complex (IEk), was synthesized with the side-chain amine of Lys99 conjugated to a photosensitive protecting group, 6-nitroveratryloxycarbonyl (NVOC). Cells plated on supported bilayers displaying mobile intercellular adhesion molecule-1 (ICAM-1) and NVOC-MCC loaded IEk did...
The identification of endogenously produced antigenic peptides presented by MHC class I molecules ha...
The innate control of adaptive immunity has been the target of various therapeutics. By the chemical...
CD8+ cytotoxic T lymphocytes (CTLs) bind to and selectively lyse tumor cells via T-cell receptor rec...
The immune system makes use of major histocompatibility complex class I (MHC I) molecules to present...
A given T cell receptor (TCR) can robustly discern a pathogen-derived agonist peptide amidst a myria...
A given T cell receptor (TCR) can robustly discern a pathogen-derived agonist peptide amidst a myria...
A novel procedure is presented describing the induction of antigen-specific cytolytic T lymphocytes ...
Class I major histocompatibility complexes (MHCs) present peptide ligands on the cell surface for re...
The interaction of the T cell antigen receptor with a photoreactive antigenic peptide derivative bou...
Using a direct binding assay based on photoaffinity labeling, we have studied the interaction of ant...
Using a direct binding assay based on photoaffinity labeling, we have studied the interaction of ant...
We used stepwise photochemical cross-linking for specifically assembling soluble and covalent comple...
Which molecular events control the initiation of a T cell response? In this issue of Immunity, Huse ...
grantor: University of TorontoSince antigen-specific auto-aggressive T cells have been fou...
grantor: University of TorontoSince antigen-specific auto-aggressive T cells have been fou...
The identification of endogenously produced antigenic peptides presented by MHC class I molecules ha...
The innate control of adaptive immunity has been the target of various therapeutics. By the chemical...
CD8+ cytotoxic T lymphocytes (CTLs) bind to and selectively lyse tumor cells via T-cell receptor rec...
The immune system makes use of major histocompatibility complex class I (MHC I) molecules to present...
A given T cell receptor (TCR) can robustly discern a pathogen-derived agonist peptide amidst a myria...
A given T cell receptor (TCR) can robustly discern a pathogen-derived agonist peptide amidst a myria...
A novel procedure is presented describing the induction of antigen-specific cytolytic T lymphocytes ...
Class I major histocompatibility complexes (MHCs) present peptide ligands on the cell surface for re...
The interaction of the T cell antigen receptor with a photoreactive antigenic peptide derivative bou...
Using a direct binding assay based on photoaffinity labeling, we have studied the interaction of ant...
Using a direct binding assay based on photoaffinity labeling, we have studied the interaction of ant...
We used stepwise photochemical cross-linking for specifically assembling soluble and covalent comple...
Which molecular events control the initiation of a T cell response? In this issue of Immunity, Huse ...
grantor: University of TorontoSince antigen-specific auto-aggressive T cells have been fou...
grantor: University of TorontoSince antigen-specific auto-aggressive T cells have been fou...
The identification of endogenously produced antigenic peptides presented by MHC class I molecules ha...
The innate control of adaptive immunity has been the target of various therapeutics. By the chemical...
CD8+ cytotoxic T lymphocytes (CTLs) bind to and selectively lyse tumor cells via T-cell receptor rec...